이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Community Narratives
Narratives bring a range of perspectives from our community.
WA
Based on Analyst Price Targets
Strategic Initiatives And Analytical Optimism Signal Bright Future In Healthcare Sector
US$603.65
FV
7.46%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
2 days ago author updated this narrative
Elevance Health, Inc. 경쟁사
가격 내역 및 성능
과거 주가 | |
---|---|
현재 주가 | US$430.77 |
52주 최고치 | US$567.26 |
52주 최저치 | US$397.98 |
베타 | 0.83 |
11개월 변경 | -20.15% |
3개월 변경 사항 | -13.87% |
1년 변경 사항 | -5.07% |
33년 변화 | -0.59% |
5년 변화 | 63.75% |
IPO 이후 변화 | 2,006.45% |
최근 뉴스 및 업데이트
Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
Oct 17Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%
Oct 10Recent updates
Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds
Oct 17Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%
Oct 10Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Oct 08Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)
Sep 11Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth
Sep 06There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital
Aug 29Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching
Aug 02Elevance Health: Healthcare Services Segment Is Gaining Traction
Jul 31Elevance Health: Buy A Dividend Growth Machine
Jul 18Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)
Jun 28Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?
Jun 11Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
May 27We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation
May 09Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63
Apr 25Elevance Health: It's Not Too Late To Buy Their Dividend Growth
Apr 23Is Elevance Health (NYSE:ELV) Using Too Much Debt?
Apr 16Elevance Health: Not Doing Enough In 2024 To Justify Premium Price
Apr 11Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors
Apr 01Elevance: A Healthy Dose Of Dividend Growth
Mar 21Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Mar 07Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63
Feb 19Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Jan 26Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement
Jan 19Is Elevance Health (NYSE:ELV) A Risky Investment?
Jan 02Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story
Dec 18A Look At Elevance's Margin Dynamics
Nov 23Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?
Nov 16Elevance Health: A High Conviction Defensive Blue Chip Buy
Oct 19These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely
Oct 04Elevance: Pave The Way For The Next UnitedHealth
Sep 21Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Sep 18Here's The Price I Would Buy Elevance Health Stock
Sep 13If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity
Aug 18Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
Aug 04Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental
Jul 24Elevance Health: Beaten Down Share Price Offers Solid Potential
Jul 10Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly
Jul 05Elevance Health: A Critical Update (Rating Downgrade)
Jun 05Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher
Jun 04Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?
May 05We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt
Apr 04Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48
Feb 17Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital
Feb 13Elevance Health: Attractive On Its Expansion Catalysts
Feb 09Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48
Jan 28주주 수익률
ELV | US Healthcare | US 마켓 | |
---|---|---|---|
7D | -14.2% | -3.2% | 1.1% |
1Y | -5.1% | 4.0% | 36.0% |
수익률 대 산업: ELV 지난 1년 동안 6.3 %를 반환한 US Healthcare 업계보다 저조한 성과를 냈습니다.
수익률 대 시장: ELV 지난 1년 동안 25.3 %를 반환한 US 시장보다 저조한 성과를 냈습니다.
가격 변동성
ELV volatility | |
---|---|
ELV Average Weekly Movement | 4.1% |
Healthcare Industry Average Movement | 6.9% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 14.7% |
10% least volatile stocks in US Market | 3.1% |
안정적인 주가: ELV 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.
시간에 따른 변동성: ELV 의 주간 변동성( 4% )은 지난 1년 동안 안정적인 모습을 보였습니다.
회사 소개
설립 | 직원 | CEO | 웹사이트 |
---|---|---|---|
2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
는 자회사와 함께 미국에서 건강 보험 회사로 운영되고 있습니다. 이 회사는 네 가지 부문으로 운영됩니다: 건강 혜택, CarelonRx, Carelon 서비스, 기업 및 기타. 프로그램 가입자에게 다양한 건강 플랜과 서비스, 건강 제품, 다양한 수수료 기반 관리형 관리 서비스, 실손, 치과, 시력, 생명, 장애 및 추가 건강 보험 혜택과 같은 특수 및 기타 보험 상품과 서비스를 제공합니다.
Elevance Health, Inc. 기본 사항 요약
ELV 기본 통계 | |
---|---|
시가총액 | US$103.05b |
수익(TTM) | US$6.42b |
수익(TTM) | US$174.02b |
15.6x
P/E 비율0.6x
P/S 비율ELV 주가가 과대평가되어 있나요?
공정 가치 및 가치 분석 보기수익 및 수익
ELV 손익 계산서(TTM) | |
---|---|
수익 | US$174.02b |
수익 비용 | US$125.40b |
총 이익 | US$48.61b |
기타 비용 | US$42.20b |
수익 | US$6.42b |
최근 보고된 수익
Sep 30, 2024
다음 수익 날짜
n/a
주당 순이익(EPS) | 27.67 |
총 마진 | 27.94% |
순이익 마진 | 3.69% |
부채/자본 비율 | 61.9% |
ELV 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기